Conference Day 2
Wednesday, September 13th, 2017
10:20 AM Scaling Up Or Scaling Out: How Oxford Biomedica Ensured Their Manufacturing Process Was Market Ready
- Examine how Oxford BioMedica performed a gap analysis to identify critical areas of development for their manufacturing strategy to meet market demand
- Hear how Oxford BioMedica assessed market requirements and current manufacturing capabilities to assist in identifying whether to scale up or scale out their manufacturing process.
- Discuss the ramifications of selecting a scale up or scale out approach: How Oxford BioMedica managed this transition to minimise process disruption and delay